BackLB PharmaceuticalsCommon Stock Overview

LB PharmaceuticalsCommon Stock Total Current Liabilities

Latest total current liabilities for LBRX: $11M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$10.91M

Peer average

Loading

LB PharmaceuticalsCommon Stock Total Current Liabilities History

Loading

LB PharmaceuticalsCommon Stock vs. peers: Total Current Liabilities Comparison

Loading

LB PharmaceuticalsCommon Stock Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

LB PharmaceuticalsCommon Stock (LBRX) FAQ

LB PharmaceuticalsCommon Stock (LBRX) currently reports a total current liabilities of $11M as of March 2026. Use the charts on this page to explore LB PharmaceuticalsCommon Stock's total current liabilities history and peer comparisons.

LB PharmaceuticalsCommon Stock reported $11M in total current liabilities as of March 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $11M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for LB PharmaceuticalsCommon Stock, and consider following LBRX for alerts when major investors trade the stock.

LB PharmaceuticalsCommon Stock is classified in the Healthcare sector. On total current liabilities, it currently shows $11M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LBRX with unrelated industries.